PT - JOURNAL ARTICLE AU - Bishton, Mark AU - Stilwell, Peter AU - Card, Tim R AU - Lanyon, Peter AU - Ban, Lu AU - Elliss-Brookes, Lucy AU - Manson, Jessica AU - Nanduri, Vasanta AU - Earp, Kate AU - Flower, Luke AU - Amarnani, Raj AU - Rankin, Judith AU - Sen, Ethan S AU - Tattersall, Rachel S AU - Crooks, Colin J AU - Aston, Jeanette AU - Siskova, Veronika AU - West, Joe AU - Bythell, Mary TI - A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population-based health data AID - 10.1101/2021.05.18.21257169 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.18.21257169 4099 - http://medrxiv.org/content/early/2021/05/18/2021.05.18.21257169.short 4100 - http://medrxiv.org/content/early/2021/05/18/2021.05.18.21257169.full AB - We assessed the validity of coded health care data to identify cases of haemophagocytic lymphohistiocytosis (HLH). Hospital Episode Statistics (HES) identified 127 cases within five hospital Trusts 2013-2018 using ICD-10 codes D76.1, D76.2 and D76.3. Hospital records were reviewed to validate diagnoses. 73/74 patients with confirmed/probable HLH were coded D76.1 or D76.2 (positive predictive value 89.0% [95% CI 80.2-94.9%]). For cases considered not HLH, 44/53 were coded D76.3 (negative predictive value 97.8% [95% CI 88.2%-99.9%]). D76.1 or D76.2 had 68% sensitivity in detecting HLH compared to an established active case finding HLH register in Sheffield. Office for National Statistics (ONS) mortality data (2003-2018) identified 698 patients coded D76.1, D76.2 and D76.3 on death certificates. 541 were coded D76.1 or D76.2 of whom 524(96.9%) had HLH in the free text cause of death. Of 157 coded D76.3, 66(42.0%) had HLH in free text.D76.1 and D76.2 codes reliably identify HLH cases, and provide a lower bound on incidence. Non-concordance between D76.3 and HLH excludes D76.3 as an ascertainment source from HES. Our results suggest electronic health care data in England can enable population wide registration and analysis of HLH for future research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for the study was supplied by a grant from the the charity Histio UK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted under the provisions of Section 251 of the NHS Act 2006. The protocol for this work was reviewed by the Public Health England (PHE) Research Ethics and Governance Group, which is the PHE Research Ethics Committee, and was found to be fully compliant with all regulatory requirements. As no regulatory or ethical issues were identified, it was agreed that a full ethical review would not be needed, and the protocol was approved.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were accessed and processed under section 251 of the NHS Service Act 2006. The section 251 permission granted to NCARDRS (CAG 10-02(d)/2015) is the only mechanism by which confidential patient information can be transferred without the discloser being in breach of the common law duty of confidentiality in England. patient level data is therefore not available.